Paul D. Bieniasz focuses on Virology, Viral replication, Tetherin, Virus and Viral envelope. He has researched Virology in several fields, including Epitope, Genetics, Antibody and Protein domain. The study incorporates disciplines such as Interferon, Reverse transcriptase and Gene in addition to Viral replication.
His Tetherin study integrates concerns from other disciplines, such as Human Immunodeficiency Virus Proteins, Ebola virus, Cell membrane and Function. His work deals with themes such as RNA and In vitro, which intersect with Virus. Paul D. Bieniasz interconnects Budding, Cell biology, Protein targeting, Virion assembly and Consensus sequence in the investigation of issues within Viral envelope.
Paul D. Bieniasz mainly focuses on Virology, Antibody, Virus, Cell biology and Viral replication. His Virology research is multidisciplinary, relying on both Epitope, Gene and Severe acute respiratory syndrome coronavirus 2. The Antibody study which covers Coronavirus that intersects with Avidity.
His work in Virus tackles topics such as Antigen which are related to areas like Titer. His study in Cell biology is interdisciplinary in nature, drawing from both Ubiquitin and Cell membrane. His work is dedicated to discovering how Viral replication, Interferon are connected with Innate immune system and other disciplines.
Paul D. Bieniasz spends much of his time researching Antibody, Virology, Virus, Neutralization and Severe acute respiratory syndrome coronavirus 2. His research investigates the connection between Antibody and topics such as Coronavirus that intersect with issues in Avidity. Paul D. Bieniasz is involved in the study of Virology that focuses on Vaccination in particular.
His Virus study incorporates themes from RNA, Antigen and Immunity. Paul D. Bieniasz combines subjects such as Spike Protein and Immune system with his study of Severe acute respiratory syndrome coronavirus 2. His research integrates issues of Interferon, Ex vivo, Reverse transcription polymerase chain reaction and Cell biology in his study of Viral replication.
Paul D. Bieniasz mainly investigates Antibody, Virology, Neutralization, Virus and Epitope. The Antibody study combines topics in areas such as Immunity and Coronavirus. His Virology study combines topics from a wide range of disciplines, such as Potency and Monoclonal antibody.
As part of the same scientific family, he usually focuses on Neutralization, concentrating on Titer and intersecting with Immunization. In his work, Seroprevalence, Viral replication, Protein domain and Infectious disease is strongly intertwined with Vaccination, which is a subfield of Virus. His research in Epitope intersects with topics in Antibody response, Spike Protein, Coronavirus disease 2019, Severe acute respiratory syndrome coronavirus 2 and Viral entry.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
Stuart J. D. Neil;Trinity Zang;Paul D. Bieniasz.
A diverse range of gene products are effectors of the type I interferon antiviral response
John W Schoggins;Sam J. Wilson;Maryline Panis;Mary Y. Murphy.
Convergent antibody responses to SARS-CoV-2 in convalescent individuals.
Davide F. Robbiani;Davide F. Robbiani;Christian Gaebler;Frauke Muecksch;Julio C.C. Lorenzi.
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry.
Matthew J. Evans;Thomas von Hahn;Donna M. Tscherne;Andrew J. Syder.
HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress
Juan Martin-Serrano;Trinity Zang;Paul D. Bieniasz.
Nature Medicine (2001)
Tetherin Inhibits HIV-1 Release by Directly Tethering Virions to Cells
David Perez-Caballero;Trinity Zang;Trinity Zang;Alaleh Ebrahimi;Alaleh Ebrahimi;Matthew W. McNatt;Matthew W. McNatt.
HIV Restriction Factors and Mechanisms of Evasion
Michael H. Malim;Paul D. Bieniasz.
Cold Spring Harbor Perspectives in Medicine (2012)
Intrinsic immunity: a front-line defense against viral attack.
Paul D Bieniasz.
Nature Immunology (2004)
HIV therapy by a combination of broadly neutralizing antibodies in humanized mice
Florian Klein;Ariel Halper-Stromberg;Joshua A. Horwitz;Henning Gruell;Henning Gruell.
MX2 is an interferon-induced inhibitor of HIV-1 infection
Melissa Kane;Melissa Kane;Shalini S. Yadav;Julia Bitzegeio;Julia Bitzegeio;Sebla B. Kutluay;Sebla B. Kutluay.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: